AUTHORS
Bret Jensen
Recent Articles By The Author
What Insiders Are Buying
Three names are seeing significant insider purchases in a market that is seeing little of this sort of activity.
BioMarin's FDA Setback Opens New Opportunities for the Stock
A simple covered call strategy seems appropriate here.
Evidence of the Great Exodus From Big Cities Mounts
The outmigration from the nation's urban hubs likely is only just beginning and will have impacts, positive and negative, for years to come.
Let's Head Overseas for a Trio of Undervalued Healthcare Plays
These promising companies look like good names for patient buy-and-hold investors.
2 Biotech Stocks to Buy on Solid Q2 Results
Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.
A Long-Term Play on Axsome Therapeutics
This covered call strategy takes patience, but it is worth it for a potential 65% return.
A Few Great Migration Plays to Consider Amid Exodus From Big Cities
Home improvement and supply concerns and homebuilders should do well as the movement from big cities to smaller towns gains traction.
Impacts, Surprising and Not, From the Coronavirus and Civil Strife
There are business sectors that are doing better than anticipated and others that are benefiting as thought from events of the day.
A Few Infrastructure Names to Build a Portfolio Upon
Like Tutor Perini, Sterling Construction and Great Lakes Dredge & Dock offer promising prospects as construction projects continue amid the pandemic.
August Feels Dangerous, but There Still Are Stocks to Target
Among the companies that seem to be managing the challenges of 2020 quite well is Pluralsight Inc.
Oops!
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Please Join or Log In to Email Our Authors.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login